Key facts
- Aignosis’s last known valuation is $2.5M (Oct 2025).
- It has raised $440K; the latest was Early Stage VC ($410K) in Oct 2025.
- Notable investors include Antler, Aman Gupta, Peyush Bansal, Nikhil Kamath, Amit Jain — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Aignosis
- ·The full record, as it builds
Funding rounds
No funding rounds for Aignosis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aignosis
Developer of an early autism detection technology designed to ensure that every child has the opportunity to thrive by meeting their developmental milestones. The company's technology leverages artificial intelligence to deliver accurate, affordable, and non-invasive screening, enabling families, educators, and clinicians with actionable insights, fostering early intervention.
- Sector
- Healthcare
- HQ
- Jaipur, India
- Founded
- 2024
- Employees
- 10
- Website
- aignosis.in/
- Ownership
- Privately Held (backing)
Aignosis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aignosis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aignosis in its N-PORT filings yet. We sweep new filings monthly.